Tag: PAE

A minimally invasive treatment using MRI and transurethral ultrasound instead of surgery or radiation is effective in treating prostate cancer, according to new research...

Interventional News’ most popular stories from August include a commentary on intra-arterial approaches to advanced pancreatic cancer; perspectives on 25 years of day-case IR...

Petra Svarc (Rigshospitalet, Copenhagen, Denmark) presented during the scientific paper session at the European Conference on Embolotherapy (ET; 21–24 June, Valencia, Spain). She imparted...

A French group of interventional radiologists and urologists has recently published the results of its randomised, multicentre, open-label, phase 3 superiority trial of prostate...

On 5 June, the Society of Interventional Radiology (SIR) held a briefing in Washington DC, USA, of which the focus was benign prostate hyperplasia...

Prostate artery embolization (PAE) provides long-term effectiveness in treating urinary symptoms from an enlarged prostate gland, according to new research to be presented at...

 Speaking to Interventional News at the recent Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2022 annual meeting (10–14 September, Barcelona, Spain), Arthur Rocha (São Paulo,...

Interventional News 87 Highlights: Ten-year data on PAE for benign prostatic hyperplasia The success of interventional radiology outpatient clinics Profile: Alban Denys Diversity in...

Interventional News 87 Highlights: Ten-year data on PAE for benign prostatic hyperplasia The success of interventional radiology outpatient clinics IR awareness: an initiative run...

Prostate conditions and their treatment proved popular reading topics during the month of July. Interventional News reported on this subject from various angles—from an...

Tiago Bilhim (Saint Louis Hospital, Lisbon, Portugal) presented during the Scientific Paper session at this year’s European Conference on Embolotherapy (22–25 June, Nice, France),...

Prostate artery embolization (PAE) is more cost-effective than transurethral resection of the prostate (TURP), the gold standard for the management of patients with benign...

There are substantial differences amongst guideline recommendations regarding the use of prostate artery embolization (PAE) in the treatment of lower urinary tract symptoms/benign prostatic...

Shivank Bhatia and Vedant Acharya highlight the importance of multidisciplinary collaboration between urologists and interventional radiologists when it comes to forming a successful prostate...

Prostate artery embolization (PAE) is a good treatment option for patients with benign prostatic hyperplasia (BPH) with minimal complications, according to the 24-month results...

In an entirely new endeavour for Yttrium-90 (Y-90) radioembolization, investigators from Northwestern University, Chicago, USA, have used the technique for the treatment of prostate...

Repeat prostatic artery embolization (PAE) is safe and effective for recurrence of lower urinary tract symptoms (LUTS) or acute urinary retention caused by benign...

Ten-year data published in Radiology show that prostate artery embolization (PAE) is a safe and effective treatment for men with benign prostatic hyperplasia (BPH),...

The improvements in quality of life measurements and International Prostate Symptom Score (IPSS) in patients following prostatic artery embolization (PAE) are “far superior” to...

With widespread urological acceptance of prostate artery embolization (PAE) impending, Tiago Bilhim (Saint Louis Hospital, Lisbon, Portugal) calls for caution when selecting patients for...

Prostate artery embolization (PAE) may become the standard of care procedure for the management of symptomatic benign prostatic hyperplasia (BPH), proposed Tiago Bilhim (CHULC,...

Hammed Ninalowo (Lagos, Nigeria) and Scott McLafferty (Columbus Radiology Corporation, Cincinnati, USA) performed the first prostate artery embolization (PAE) in Nigeria on 29 August...

The American Urological Association (AUA) have published guideline amendments in the September issue of The Journal of Urology, but have not changed their stance...

Balloon-occlusion prostatic artery embolization (PAE) is as effective as conventional microcatheter PAE in the treatment of benign prostatic hyperplasia (BPH) with a potential to...

Prostate artery embolization (PAE) outcomes do not differ significantly when microspheres of different sizes are used as embolic agents, a recent single centre, randomised...

Current evidence supports the use of prostate artery embolization (PAE) as a safe, effective, and minimally-invasive treatment for the symptoms of benign prostatic hyperplasia...

Described by her supervisor Glen Schlaphoff (Sydney, Australia) as "a perfect example of a young up and coming interventional radiologist", Sindhura Nirmalarajan is a...

A prospective US FDA-approved investigational device exemption (IDE) study has demonstrated significant improvement in lower urinary tract symptoms secondary to benign prostatic hyperplasia and...

Boston Scientific showed at the Global Embolization Cancer Symposium and Technologies (GEST US; 17–19 May, Miami Beach, USA) meeting that the US Food and...

https://www.youtube.com/watch?v=QH9H-hwdb6o&feature=youtu.be Francesco Carnevale (São Paulo, Brazil) speaks on the growing acceptance for prostatic artery embolization. The national regulatory bodies in Brazil and the UK recommending...

First results from the UK-ROPE multicentre registry reveal that prostatic artery embolization is highly effective in reducing lower urinary tract symptoms in men with benign prostatic obstruction.

Six-month results from a prospective, randomised, non-inferiority study presented at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE; 16–20 September, Copenhagen, Denmark) reveal...

Merit Medical has announced that it has received 513(f)(2) (de novo) classification from the FDA to expand indication for its Embosphere microspheres. The indication...

According to our results, the physician who performs prostatic artery embolization procedures, even with a ceiling suspended shield, would reach the annual radiation limit...

A study recently published in Cardiovascular and Interventional Radiology has, for the first time, identified adenomatous-dominant benign prostatic hyperplasia as a predictor of clinical...

Prostate artery embolization maintains its effectiveness for at least three years after patients undergo the therapy, according to research presented at the Society of...

Mentice has announced the release of the world’s first simulation training software module for prostatic artery embolization. The software, created from real patients’ data,...